Blanket hepatitis B vaccination is questionable in India

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7547.976 (Published 20 April 2006) Cite this as: BMJ 2006;332:976
  1. Peter R Mansfield, director (peter.mansfield@adelaide.edu.au),
  2. Anant Phadke,
  3. Ashok Kale
  1. Healthy Skepticism, Willunga, SA 5041, Australia

    EDITOR—We agree with Banatvala et al that adequate economic analysis of universal hepatitis B vaccination is required before recommending policy change in Britain.1 In India plans for universal hepatitis B vaccination have been announced without an economic comparison with other programmes that may be more cost effective.

    The marginal cost-efficacy of hepatitis B vaccine in India has been estimated, …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription